Indexes | NCA (n = 8) | NSTEMI (n = 7) | STEMI (n = 6) | P value |
---|---|---|---|---|
Age, years | 53.75 ± 5.90 | 58.43 ± 6.19 | 53.50 ± 8.55 | 0.339 |
Sex (F/M) | 5/3 | 6/1 | 4/2 | 0.583 |
Risk factor | ||||
 Smoker | 0 | 4 | 3 | 0.038 |
 Triglycerides, mmol/L | 1.63 ± 0.82 | 2.16 ± 1.23 | 2.24 ± 0.97 | 0.469 |
 Cholesterol, mmol/L | 4.66 ± 1.35 | 5.42 ± 1.59 | 5.91 ± 1.40 | 0.291 |
 HDL, mmol/L | 1.28 ± 0.30 | 1.03 ± 0.30 | 1.41 ± 0.25 | 0.072 |
 LDL, mmol/L | 2.39 ± 0.85 | 3.25 ± 0.93 | 3.24 ± 0.65 | 0.102 |
 cTnI, ng/mL | 0.010 ± 0.021 | 0.476 ± 0.282 | 14.533 ± 21.287 | 0.053 |
 BNP, pg/mL | 1350.22 ± 3391.04 | 4352.33 ± 6905.50 | 2021.00 ± 1861.27 | 0.447 |
 CD3+ T lymphocyte cell count (/µL) | 1438.63 ± 197.60 | 1509.29 ± 309.61 | 1362.83 ± 201.80 | 0.563 |
Clinical records | ||||
 Aspirin | 2 | 5 | 1 | 0.080 |
 Clopidogrel | 0 | 5 | 1 | 0.007 |
 Statins | 0 | 2 | 1 | 0.283 |
 ACEI/ARB | 0 | 1 | 1 | 0.501 |
 Ca2+ antagonist | 0 | 0 | 0 | NA |
 β-blocker | 1 | 0 | 1 | 0.556 |